AP: Scientists have yet to find a treatment for the SARS virus, but already a race is on to patent it.

Several biotechnology and pharmaceutical companies, the federal government and researchers in Canada and Hong Kong have filed SARS-related patent applications in recent weeks, claiming ownership of everything from bits of genetic material to the virus itself.